share_log

EFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW) Sees Significant Decline in Short Interest

EFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW) Sees Significant Decline in Short Interest

EFFECTOR Therapeutics, Inc.(納斯達克股票代碼:EFTRW)預計空頭利率大幅下降
Financial News Live ·  2023/01/01 22:31

eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) was the recipient of a significant decrease in short interest in December. As of December 15th, there was short interest totalling 26,800 shares, a decrease of 23.9% from the November 30th total of 35,200 shares. Based on an average trading volume of 16,000 shares, the days-to-cover ratio is presently 1.7 days.

Effector Therapeutics, Inc.(納斯達克股票代碼:EFTRW — 獲取評級)是12月空頭利率大幅減少的接受者。截至12月15日,空頭利息總額爲26,800股,較11月30日的35,200股減少了23.9%。根據16,000股的平均交易量,目前的交易天數比率爲1.7天。

eFFECTOR Therapeutics Price Performance

Effector 治療的價格表現

NASDAQ EFTRW remained flat at $0.16 on Friday. The company has a fifty day moving average of $0.13 and a 200-day moving average of $0.17. eFFECTOR Therapeutics has a fifty-two week low of $0.04 and a fifty-two week high of $0.99.

週五,納斯達克EFTRW持平至0.16美元。該公司的五十天移動平均線爲0.13美元,200天移動平均線爲0.17美元。Effector Therapeutics的五十二週低點爲0.04美元,五十二週高點爲0.99美元。

Featured Stories

精選故事

  • Get a free copy of the StockNews.com research report on eFFECTOR Therapeutics (EFTRW)
  • MarketBeat: Week in Review 12/26 – 12/30
  • The Dogs Of Tech: It's Time For A Bite Of These Stocks
  • Does This Acquisition Make Microsoft a Bear Market Buy?
  • Is Kintara Therapeutics A Hidden Gem?
  • Should You Warm up to Generac Stock for the Winter?
  • 免費獲取 StockNews.com 關於 Effector Therapeutics(EFTRW)的研究報告
  • MarketBeat:本週回顧 12 月 26 日 — 12 月 30 日
  • 科技之狗:是時候咬一口這些股票了
  • 此次收購會使微軟成爲熊市買入嗎?
  • 金塔拉療法是隱藏的寶石嗎?
  • 你應該爲冬天的 Generac Stock 做熱身嗎?

Receive News & Ratings for eFFECTOR Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eFFECTOR Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

每天接收 Effector Therapeutics 的新聞 -在下面輸入您的電子郵件地址,即可通過Marketbeat.com的免費每日電子郵件時事通訊接收Effector Therapeutics及相關公司的最新新聞和分析師評級的簡明每日摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論